QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids

American Journal of Cardiology

Volumn 84, Issue 3, 1999, Pages 364-366

  Stolt, Anu ^a   Karila, Tuomo ^b   Viitasalo, Matti ^a   Mäntysaari, Matti ^c   Kujala, Urho M ^a   Karjalainen, Jouko ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c CENTRAL MILITARY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; STEROID;

ADAPTATION; ADULT; ARTICLE; ATHLETE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; QT INTERVAL; STEROID THERAPY; VAGUS TONE;

ADRENAL CORTEX HORMONES; CASE-CONTROL STUDIES; FINLAND; HEART CONDUCTION SYSTEM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; RUNNING; SPORTS; TIME FACTORS;

EID: 0033180057     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00299-4     Document Type: Article

References (15)

1. Karjalainen J., Reunanen A., Ristola P., Viitasalo M. QT interval as a cardiac risk factor in a middle aged population. Heart. 77:1997;543-548.
2. Zabel M., Portnoy S., Franz M.R. Electrocardiographic indexes of dispersion of ventricular repolarization an isolated heart validation study . J Am Coll Cardiol. 25:1995;746-752.
3. Pye M., Quinn A.C., Cobbe S.M. QT-interval dispersion a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J. 71:1994;511-514.
4. Higham P.D., Campbell R.W.F. QT dispersion. Br Heart J. 71:1994;508-510.
5. Mänttäri M., Oikarinen L., Manninen V., Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart. 78:1997;268-272.
6. Perkiömäki J.S., Ikäheimo M.J., Pikkujämsä S.M., Rantala A., Lilja M., Kesäniemi Y.A., Huikuri H.V. Dispersion of QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension. 28:1996;16-21.
7. Mayet J., Shahi M., McGrath K., Poulter N.R., Sever P.S., Foale R.A., Thom S.A.M. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension. 28:1996;791-796.
8. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.C. Sudden death in young competitive athletes. JAMA. 276:1996;199-204.
9. Nieminen M.S., Rämö M.P., Viitasalo M., Heikkilä P., Karjalainen J., Mäntysaari M., Heikkilä J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J. 17:1996;1576-1583.
10. Karjalainen J., Viitasalo M., Mänttäri M., Manninen V. Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. J Am Coll Cardiol. 23:1994;1547-1553.
11. Karjalainen J., Mäntysaari M., Viitasalo M., Kujala U. Left ventricular mass, geometry and filling in endurance athletes association with exercise blood pressure . J Appl Physiol. 82:1997;531-537.
12. Deveraux R. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension. 9:(suppl II):1987;19-26.
13. Browne K.F., Zipes D.P., Heger J.J., Prystowsky E.N. Influence of the autonomic nervous system on the QT interval in man. Am J Cardiol. 50:1982;1099-1103.
14. Ferenchick G.S., Adelman S. Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J. 124:1992;507-508.
15. Gaede J.T., Montine T.J. Massive pulmonary embolus and anabolic steroid abuse. JAMA. 6:1992;2328-2329.